Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies.

Bryson GJ, Lear D, Williamson R, Wong RC.

J Clin Pathol. 2002 Jul;55(7):535-7.

2.

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

Orfao A, Schmitz G, Brando B, Ruiz-Arguelles A, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF.

Clin Chem. 1999 Oct;45(10):1708-17. Review.

3.

[Hematodermic CD4/CD56 neoplasm].

Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, D├ęchelotte P, Feuillard J, Durlach A, Vergier B.

Ann Pathol. 2004 Jun;24(3):241-55; quiz 227. Review. French.

PMID:
15480259
4.

CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

Herling M, Jones D.

Am J Clin Pathol. 2007 May;127(5):687-700. Review.

PMID:
17439829
5.

The immune system in neuroendocrine tumors.

Thiel A, Ehlers M, Anlauf M, Raffel A, Stoecklein NH, Schott M.

Horm Metab Res. 2011 Nov;43(12):890-6. doi: 10.1055/s-0031-1284382. Epub 2011 Oct 4. Review.

PMID:
21971962

Supplemental Content

Support Center